The severity criteria of the British Thoracic Society (BTS) guideline for paediatric community-acquired pneumonia (CAP) boast of a fair to excellent capacity in predicting the need for hospitalization (NFH) and disposition, a study has shown.
The 30-day all-cause mortality is similar between definitive therapy with vancomycin or a beta-lactam among patients with an ampicillin-susceptible enterococcal bloodstream infection (BSI), a recent study has shown.
Monthly supplementation with high-dose vitamin D does little to stave off the risk of developing acute respiratory infection in older adults with low prevalence of profound vitamin D deficiency, a study has found.
Women who develop infection during delivery hospitalization are at higher risk of being readmitted for ischaemic stroke within 30 days postpartum, especially those with no hypertensive disorders of pregnancy, a study reports.
A third of Clostridium difficile infection (CDI) patients with cirrhosis have been readmitted in a span of 30 days primarily due to recurrent CDI, a recent study has found. In addition, there is a high rate of mortality linked to CDI in patients with cirrhosis, in which a poor prognosis is predicted by decompensation and 30-day readmission.
The high-dose influenza vaccine confers no additional protection beyond the standard-dose vaccine (SDV) in terms of all-cause mortality or influenza-related outcomes in adults undergoing maintenance haemodialysis, as shown in a recent study.
Individuals with obesity are at an elevated risk of developing infections, particularly that of the skin in both men and women, and those of the gastrointestinal and urinary tracts and sepsis in women only, according to a study.
Infection with hepatitis B virus (HBV) does not appear to independently affect pregnancy outcomes, although it contributes to prolonged infertility, higher odds of secondary infertility, ovulatory disorders and reduced implantation rate, a study has found.
Scientists from the Department of Microbiology, University of Hong Kong (HKU) recently discovered a compound with broad antiviral activity against viruses causing Middle East Respiratory Syndrome (MERS), avian flu (H7N9), severe acute respiratory syndrome (SARS) and Zika fever.